Search

Your search keyword '"Helliwell, Philip"' showing total 1,552 results

Search Constraints

Start Over You searched for: Author "Helliwell, Philip" Remove constraint Author: "Helliwell, Philip"
1,552 results on '"Helliwell, Philip"'

Search Results

3. Patients’ perspectives on systemic sclerosis-related Raynaud's phenomenon in the feet: A qualitative study from the OMERACT Foot and Ankle Working Group

6. Developing an Outcome Measures in Rheumatology (OMERACT) Core set of Outcome Measures for FOot and ankle disorders in RheumaTic and musculoskeletal diseases (COMFORT): core domain set study protocol

8. Developing a core outcome set for foot and ankle disorders in rheumatic and musculoskeletal diseases: A scoping review and report from the OMERACT 2022 foot and ankle special interest group session

10. Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

15. Treating axial spondyloarthritis and peripheral spondyloarthritis, especially psoriatic arthritis, to target: 2017 update of recommendations by an international task force

18. Efficacy and safety of guselkumab in biologic-naïve patients with active axial psoriatic arthritis: study protocol for STAR, a phase 4, randomized, double-blinded, placebo-controlled trial

21. Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies

22. Chemical Bioconjugation of Proteins in an Undergraduate Lab: One-Pot Oxidation and Derivatization of the N-Terminus

25. Guselkumab provides durable improvement across psoriatic arthritis disease domains: post hoc analysis of a phase 3, randomised, double-blind, placebo-controlled study

26. How do patient-reported outcome measures affect treatment intensification and patient satisfaction in the management of psoriatic arthritis? A cross sectional study of 503 patients

28. High prevalence of undiagnosed and undertreated psoriasis in a UK urban population: results from the observational COPPACA study.

31. Author Correction: Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA): updated treatment recommendations for psoriatic arthritis 2021

33. Application of information theoretic feature selection and machine learning methods for the development of genetic risk prediction models

37. The comparative performance of three screening questionnaires for psoriatic arthritis in a primary care surveillance study.

39. An international multi-centre analysis of current prescribing practices and shared decision-making in psoriatic arthritis

43. Screening and Referral Strategies for the Early Recognition of Psoriatic Arthritis Among Patients With Psoriasis: Results of a GRAPPA Survey

44. Initiating Evaluation of Composite Outcome Measures for Psoriatic Arthritis: 2022 Updates From the GRAPPA-OMERACT Working Group

45. GRAPPA Historical Perspective

48. Que signifie l’évaluation globale par le patient dans le rhumatisme psoriasique ? Une analyse de 223 patients issus de l’étude d’élaboration du Psoriatic Arthritis Impact of Disease (PsAID)

Catalog

Books, media, physical & digital resources